AGN Overview
Upcoming Projects (AGN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AGN)
-
Examining a clinician's confidence in botox biosimilar clinical development programs
Tickers: VTRSV, AGN, RVNC
Executed On: Oct 14, 2022 at 08:30 AM EDT
Expired Projects (AGN)
Upcoming & Overdue Catalysts (AGN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AGN)
-
Allergran (AGN) and Paratek (PRTK) expecting approval for Sarecycline, an antibiotic designed to treat inflammatory acne
Tickers: AGN, PRTK
Occurred on: Oct 03, 2018 -
Allergran (AGN) and Paratek (PRTK) set to file NDA for Sarecycline, an antibiotic designed to treat inflammatory acne, in 2H 2017
Tickers: AGN, PRTK
Occurred on: Dec 20, 2017 -
FDA Approval For Allergan's CoolSculpting Treatment To Improve Appearance Of Lax Tissue In The Double Chin
Ticker: AGN
Occurred on: Dec 12, 2017 -
PDUFA estimate September 4, 2017 for LILETTA (levonorgestrel-releasing intrauterine system) 52 mg, for the prevention of pregnancy
Ticker: AGN
Occurred on: Aug 07, 2017 -
Allergan's (AGN) Juvederm Vollure XC Approved by FDA for the Correction of Moderate-to-Severe Facial Wrinkles and Folds
Ticker: AGN
Occurred on: Mar 20, 2017 -
Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Ticker: AGN
Occurred on: Jan 17, 2017 -
Allergan's (AGN) XEN Gel Stent Approved by FDA to Reduce Intraocular Pressure (IOP) in Treatment-Resistant Glaucoma Patients
Ticker: AGN
Occurred on: Nov 22, 2016 -
Allergan (AGN) Announces Commercial Launch of TAYTULLA Softgel Capsule Oral Contraceptive for the Prevention of Pregnancy
Ticker: AGN
Occurred on: Nov 10, 2016 -
Allergan (AGN) to complete Phase 3 study of of Vilazodone in Adolescent Patients With Major Depressive Disorder in summer 2016
Ticker: AGN
Occurred on: Oct 06, 2016 -
Allergan (AGN) Announces FDA Approval of NATRELLE INSPIRA Cohesive Breast Implants
Ticker: AGN
Occurred on: Sep 23, 2016 -
Allergan (AGN) Strengthens Liver Disease Portfolio in Agreement to Acquire Tobira Therapeutics (TBRA) for ~$1.695 Billion
Tickers: AGN, TBRA
Occurred on: Sep 20, 2016 -
Allergan (AGN) Adds to Dermatology Programs in Agreement to Acquire Vitae Pharmaceuticals (VTAE) for ~$639 Million
Tickers: AGN, VTAE
Occurred on: Sep 14, 2016 -
Allergan and Richter Provide Update on Cariprazine Program in treating depression; Topline results from the MD-72 trial
Ticker: AGN
Occurred on: Aug 05, 2016 -
Allergan Receives Positive Opinion For Truberzi (Eluxadoline) For Treatment Of Irritable Bowel Syndrome With Diarrhoea (IBS-D) In Adults
Ticker: AGN
Occurred on: Jul 25, 2016 -
Allergan Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator
Ticker: AGN
Occurred on: Jul 18, 2016 -
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ (ceftazidime and avibactam)
Ticker: AGN
Occurred on: Jun 23, 2016 -
JUVÉDERM VOLBELLA XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids
Ticker: AGN
Occurred on: Jun 01, 2016 -
Allergan Receives FDA Approval of TEFLARO (ceftaroline fosamil) for Pediatric Patients
Ticker: AGN
Occurred on: May 31, 2016 -
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Ticker: AGN
Occurred on: May 24, 2016 -
Allergan Reinforces Commitment to Hypertension Management with Four Poster Presentations at ASH 2016
Ticker: AGN
Occurred on: May 16, 2016 -
Allergan Announces U.S. Availability of VRAYLAR (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Ticker: AGN
Occurred on: Mar 16, 2016 -
Allergan Receives Complete Response Letter from FDA for Prior Approval Supplement for Restasis
Ticker: AGN
Occurred on: Mar 10, 2016 -
Allergen Submits Filing to FDA for the Generic Manufacturing and Marketing of Celgene's Abraxane - Celgene to Defend it's Patent Rights
Tickers: CELG, AGN
Occurred on: Mar 07, 2016 -
Allergan (AGN) recieves FDA Acceptable for Filing Letter for Generic XIFAXAN® ANDA
Tickers: AGN, VRX
Occurred on: Feb 29, 2016 -
Allergan Announces FDA Approval of ACZONE (dapsone) Gel, 7.5% for Treatment of Acne Vulgaris
Ticker: AGN
Occurred on: Feb 25, 2016 -
FDA Accepts and Grants Priority Review for AVYCAZ (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Ticker: AGN
Occurred on: Feb 24, 2016 -
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil)
Ticker: AGN
Occurred on: Feb 16, 2016 -
Allergan's Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder
Ticker: AGN
Occurred on: Jan 29, 2016 -
Allergan's (AGN) Subsidiary Warner Chilcott to Pay $102 Million to Settle Federal Investigation
Ticker: AGN
Occurred on: Oct 29, 2015 -
Revance's (RVNC) RT002 Superior to Allergan's (AGN) BOTOX in Phase 2 Study Evaluating Treatment of Frown Lines
Tickers: RVNC, PFE, VRX, AGN
Occurred on: Oct 29, 2015 -
Allergan (AGN) Launches Over-the-counter Artificial Tear REFRESH OPTIVE Gel Drops for Dry Eye Symptoms
Tickers: AGN, PFE
Occurred on: Oct 21, 2015 -
Allergan (AGN) Issues Statement Regarding Specialty Pharmacy Utilization and Resumes Trading
Tickers: AGN, PFE, VRX
Occurred on: Oct 21, 2015 -
Allergan (AGN) Completes Acquisition of AqueSys and XEN45 for $300 Million
Tickers: AGN, PFE
Occurred on: Oct 19, 2015 -
Allergan (AGN) Presents Paper Titled "Facial Treatment Preferences in Aesthetically-Oriented Men" at American Society of Dermatologic Surgery Meeting
Tickers: AGN, PFE, VRX
Occurred on: Oct 17, 2015 -
Allergan (AGN) Presents Data From Harmony Study on Combined Facial Aesthetic Treatment With Botox, Dermal Fillers, and Bimatoprost
Tickers: AGN, PFE, VRX
Occurred on: Oct 17, 2015
Strategic Initiatives (AGN)
-
Allergan (AGN) Announces Exclusive R&D Partnership with Editas (EDIT) for Five Gene-Editing Ocular Programs
Tickers: AGN, EDIT
Announcement Date: Mar 14, 2017 -
Allergan (AGN) Completes $2.9B Acquisition of LifeCell
Tickers: AGN, LifeCell
Announcement Date: Dec 20, 2016 -
AstraZeneca (AZN) and Allergan (AGN) Complete Licensing Agreement for MEDI2070 Antibody Candidate in Mid-Stage Development for Crohn's Disease and Ulcerative Colitis
Tickers: AGN, AZN
Announcement Date: Nov 17, 2016 -
Teva Completes Acquisition of Actavis Generics
Tickers: TEVA, AGN
Announcement Date: Aug 02, 2016 -
Dr. Reddy’s to acquire product portfolio from TEVA for US Market
Ticker: AGN
Announcement Date: Jun 11, 2016 -
Cardiome and Allergan Announce XYDALBA (Dalbavancin) Licensing Agreement in International Markets
Tickers: CRME, AGN
Announcement Date: May 05, 2016 -
Allergan Acquires Topical Dermatology Company Topokine Therapeutics Adding Non-Invasive Fat Reduction Development Program
Tickers: AGN, Topokine Therapeutics
Announcement Date: Apr 21, 2016
